Truncating Tradition in the POET II Trial: Is a shorter course of antibiotics noninferior to standard length therapy in left-sided endocarditis?

Verbrugge FH, van Diepen S

Open source

DOI
10.1093/ehjacc/zuag120
Published
2026 Sep 7
Container
European heart journal. Acute cardiovascular care
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ehjacc/zuag120,
  title = {Truncating Tradition in the POET II Trial: Is a shorter course of antibiotics noninferior to standard length therapy in left-sided endocarditis?},
  author = {Verbrugge FH and van Diepen S},
  year = {2026},
  journal = {European heart journal. Acute cardiovascular care},
  doi = {10.1093/ehjacc/zuag120},
  url = {https://doi.org/10.1093/ehjacc/zuag120}
}

RIS

TY  - JOUR
TI  - Truncating Tradition in the POET II Trial: Is a shorter course of antibiotics noninferior to standard length therapy in left-sided endocarditis?
AU  - Verbrugge FH
AU  - van Diepen S
PY  - 2026
JO  - European heart journal. Acute cardiovascular care
DO  - 10.1093/ehjacc/zuag120
UR  - https://doi.org/10.1093/ehjacc/zuag120
ER  - 

APA

FH, V., & S, V. D. (2026). Truncating Tradition in the POET II Trial: Is a shorter course of antibiotics noninferior to standard length therapy in left-sided endocarditis?. European heart journal. Acute cardiovascular care. https://doi.org/10.1093/ehjacc/zuag120

Source records